Sowsan Atabani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sowsan Atabani

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Plos One|September 30, 2016

Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive TherapyPaul D Griffiths, Emily Rothwell, Mohammed Raza, et al.

Plos One|September 20, 2017

Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive TherapyPaul D Griffiths, Emily Rothwell, Mohammed Raza, et al.

Lancet (London, England)|April 13, 2011

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialPaul D Griffiths, Anna Stanton, Erin McCarrell, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Plos One|September 30, 2016

Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive TherapyPaul D Griffiths, Emily Rothwell, Mohammed Raza, et al.

Plos One|September 20, 2017

Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive TherapyPaul D Griffiths, Emily Rothwell, Mohammed Raza, et al.

Lancet (London, England)|April 13, 2011

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialPaul D Griffiths, Anna Stanton, Erin McCarrell, et al.

Pageof 2